➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
Colorcon
Baxter
Express Scripts

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Etodolac - Generic Drug Details

« Back to Dashboard

What are the generic sources for etodolac and what is the scope of freedom to operate?

Etodolac is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Apotex, Biopharm, Chartwell Molecules, Mylan, Sandoz, Taro, Wyeth Pharms Inc, Actavis Elizabeth, Bayshore Pharms Llc, Teva, Watson Labs Florida, Zydus Pharms, Amneal Pharms Co, Apotex Inc, Edenbridge Pharms, Ivax Sub Teva Pharms, Oxford Pharms, Pharmgen, Ranbaxy Labs Ltd, Taro Pharm Inds, and Watson Labs, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for etodolac. Twenty-eight suppliers are listed for this compound.

Drug Prices for etodolac

See drug prices for etodolac

Drug Sales Revenue Trends for etodolac

See drug sales revenues for etodolac

Recent Clinical Trials for etodolac

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
HaEmek Medical Center, IsraelPhase 2
Tel-Aviv Sourasky Medical CenterPhase 2
Sheba Medical CenterPhase 2

See all etodolac clinical trials

Pharmacology for etodolac
Medical Subject Heading (MeSH) Categories for etodolac
Paragraph IV (Patent) Challenges for ETODOLAC
Tradename Dosage Ingredient NDA Submissiondate
LODINE XL TABLET, EXTENDED RELEASE;ORAL etodolac 020584

US Patents and Regulatory Information for etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmgen ETODOLAC etodolac TABLET;ORAL 074846-001 Feb 28, 1997 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Edenbridge Pharms ETODOLAC etodolac TABLET;ORAL 209888-001 Nov 30, 2018 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Teva ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 075665-002 Jul 31, 2000 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for etodolac

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-002 Jan 31, 1991   Get Started Free   Get Started Free
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-003 Jan 20, 1998   Get Started Free   Get Started Free
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-003 Jan 31, 1991   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Dow
Mallinckrodt
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.